Brandt, SD and Elliott, S (2016) Technical report on 1-phenyl-2- (pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP). European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
TDAK16001ENN.pdf - Published Version
This publication presents the data and findings of the risk assessment on α-PVP (1-phenyl- 2-(1-pyrrolidinyl)-1-pentanone), carried out by the extended Scientific Committee of the EMCDDA on 18 November 2015. α-PVP is the eleventh new psychoactive substance to be risk assessed under the terms of Council Decision 2005/387/JHA. On the basis of the Risk Assessment Report — and on the initiative of the European Commission — on 27 June 2016, the Council decided that α-PVP should be subject to control measures across the Member States.
|Subjects:||R Medicine > RS Pharmacy and materia medica|
|Divisions:||Pharmacy & Biomolecular Sciences|
|Publisher:||European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)|
|Date Deposited:||23 Aug 2016 08:44|
|Last Modified:||23 Aug 2016 08:44|
Actions (login required)